Treatment of psychosis and dementia in Parkinson's disease.
about
The Efficacy and Safety of Antipsychotic Medications in the Treatment of Psychosis in Patients with Parkinson's DiseaseMolecularly and clinically related drugs and diseases are enriched in phenotypically similar drug-disease pairsEvidence for the use of pimavanserin in the treatment of Parkinson's disease psychosisUpdate on the treatment of Parkinson’s disease psychosis: role of pimavanserinThe neurobiological basis of cognitive impairment in Parkinson's disease.Atypical antipsychotic therapy in Parkinson's disease psychosis: A retrospective studyEffects of combined MAO-B inhibitors and levodopa vs. monotherapy in Parkinson's disease.Behavioral effects of levodopa.Psychosis in Parkinson's disease: identification, prevention and treatment.Missing dosages and neuroleptic usage may prolong length of stay in hospitalized Parkinson's disease patients.Parkinson's Disease and Its Management: Part 5: Treatment of Nonmotor Complications.Cognitive Impairment Associated with Parkinson's Disease: Role of Mitochondria.Patterns of Longitudinal Neural Activity Linked to Different Cognitive Profiles in Parkinson's Disease.Advances in the treatment of cognitive impairment in Parkinson's disease.Current Treatment Options for Alzheimer's Disease and Parkinson's Disease Dementia.A review of adverse events linked to dopamine agonists in the treatment of Parkinson's disease.Nondopaminergic therapy of motor and nonmotor symptoms in Parkinson's disease: a clinician's perspective.Persistence of racial disparities in prescription of first-generation antipsychotics in the USA.Management of Psychosis in Parkinson's Disease: Emphasizing Clinical Subtypes and Pathophysiological Mechanisms of the Condition.Fatigue in Parkinson's disease: The contribution of cerebral metabolic changes.Parkinson's disease psychosis as a serotonin-dopamine imbalance syndrome.Development of a UPLC-MS/MS method for determination of pimavanserin tartrate in rat plasma: Application to a pharmacokinetic study.Mechanism of action of pimavanserin in Parkinson's disease psychosis: targeting serotonin 5HT2A and 5HT2C receptors.[Evidence-based treatment of psychosis associated with Parkinson's disease].Treatment of advanced Parkinson's disease.
P2860
Q26738456-B91AC253-8A57-4584-BA57-A5E0C381FF03Q27499827-A68B9416-E8AF-4207-948B-A33BDB48138BQ28074468-9EAB785F-CA1F-42D4-93A7-E5E6880A7A92Q29048641-1B77D611-95E8-434E-B135-B3E49D03A9D5Q33724698-76F2F0D1-B550-4604-826D-478E265A333AQ33810051-5977C577-2410-4D10-8935-C310CC58D5FAQ33950517-3D53FADE-68B7-4039-A71A-D5B139235C1DQ34452922-90F5EDB2-9B10-4EEB-B029-15F6DFAE2B7DQ34669424-F0FB707C-6079-4225-8703-3B8AE504BFE0Q35464202-C20F6CF8-0051-438F-ADDC-B47DFE537D1AQ36351543-1EEC262E-2D3F-4A1B-ABF2-188C5F7BCDA9Q37168743-C3C28824-9FCC-4D6A-97D1-9578B307EC4DQ37430474-88D5EF07-2BA9-4677-A284-F9530C4E5442Q38571668-2E388590-AEDD-4B93-B7D5-487353DB49F1Q38661735-C807B722-3D7E-4E25-AC4F-775E510DE2A2Q38662579-5832F259-EB6D-48C0-97AD-057C32E1A664Q38947507-3E31AD20-9126-4606-AAE9-C5AEEF86C733Q40778551-82BE8EE3-01B4-47E6-B7A3-22832D5FA53AQ43375910-F5E5F469-A6CD-48D0-B452-B96C5BD32135Q47950883-F46C5489-7341-4BF7-BF22-58BF2B35E626Q48492369-65E447C6-83D4-4F83-A3F7-D35E151E1063Q49200036-37E2D9DB-485B-4234-9030-B4FE0F312F6EQ51583546-CE7E7929-9A50-481E-8ECA-1D408A0F6F93Q53651478-61DDC557-DF9C-43FE-B7F9-39F27B8484FCQ55645561-CAACB2DB-B65C-4C16-912E-06D08FC803B4
P2860
Treatment of psychosis and dementia in Parkinson's disease.
description
2014 nî lūn-bûn
@nan
2014 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի մարտին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Treatment of psychosis and dementia in Parkinson's disease.
@ast
Treatment of psychosis and dementia in Parkinson's disease.
@en
type
label
Treatment of psychosis and dementia in Parkinson's disease.
@ast
Treatment of psychosis and dementia in Parkinson's disease.
@en
prefLabel
Treatment of psychosis and dementia in Parkinson's disease.
@ast
Treatment of psychosis and dementia in Parkinson's disease.
@en
P2860
P921
P1476
Treatment of psychosis and dementia in Parkinson's disease
@en
P2093
Jennifer G Goldman
P2860
P2888
P356
10.1007/S11940-013-0281-2
P577
2014-03-01T00:00:00Z